Navigation Links
Nastech to Host 2007 Analyst and Institutional Investor Day
Date:9/26/2007

njectable drug delivery technology as well as the development of RNAi therapeutics and now has a strong pipeline of products in or preparing to initiate Phase II clinical trials," stated Steven C. Quay, M.D., Ph.D., Chairman, President and Chief Executive Officer of Nastech. "For this year's analyst and institutional investor day event, Nastech is pleased to have gathered leading experts in their respective fields to highlight three areas at the core of Nastech's drug development. This event will also lend insight into Nastech's technologies and business, as we continue to execute upon a strategy that we believe has the potential to deliver important therapies to patients while creating significant value for our shareholders."

The invitation-only event will be webcast commencing at 12:30 p.m. Eastern Time. To access the live webcast for this conference, please log on to Nastech's website at http://www.nastech.com approximately 15 minutes prior to the presentation in order to register and download any necessary software.

About Nastech

Nastech is a biopharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. Nastech and our collaboration partners are developing products for multiple therapeutic areas including osteoporosis, obesity, diabetes, autism, respiratory diseases and inflammatory conditions. Additional information about Nastech is available at http://www.nastech.com.

Nastech Forward-Looking Statements

Statements made in this press release may be forward-looking statements within the meaning of Federal Securities laws that are subject to certain risks and uncertainties and involve factors that may cause actual results to differ materially from those projected or suggested. Factors that could cause actual results to differ materially from those in forward-looking s
'/>"/>

SOURCE Nastech Pharmaceutical Company Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. measurement of green fluorescent proteins and a red fluorescent protein in live cells in the Analyst GT multimode reader
2. Venture Investors early-stage fund grows to $115 million
3. Investor warns of angel-venture funding gap
4. Brazilian bio-industry should impress American investors
5. Investors raise $25 million for biodiesel plant
6. Bio-energy and cleantech grab attention of investors
7. Venture Investors to open Michigan office
8. Early-stage executives hear from investors
9. Commerce qualifies seven for investor tax credits
10. Investor links East Coast funds to Midwest tech
11. Angel investors commit $12.7B in first half of `06
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2008)...arma, a leading provider of,knowledge management s...ce,industry, announced today that the Aureus Pharm...ober 23rd and 24th., This symposium follows last ... attended by many of Aureus, pharmaceutical and bi.... The symposium included presentations,from indust...
(Date:7/2/2008)...e/ -- Research conducted at The,Walter and Eliza H... to a,major licensing agreement signed between Aus...) and Germany-based pharmaceutical company, Merck,...ement, Merck Serono will seek,to develop new treat...mune,conditions. These prospective treatments will...
(Date:7/1/2008)...rstCall/ -- Schering-Plough,Corporation (NYSE: SG...previously announced transaction with Virbac, S.A....anchises. These divestments were requested by the,...earance of the,acquisition of Organon BioSciences ...e endocrine, mastitis and,sulphonamide franchises ...
(Date:7/1/2008)... Microfluidic Systems Inc.,(MFSI) announced today ...r,the production of Microfluidic - Bioagent Autono...e fourth in a series of funded phases by the DHS,S...continued funding,through March 2009, will allow f...extended field trials in key locations around the ...
Breaking Biology Technology:Aureus Pharma Announces Date of 2008 Annual User Symposium 2MS Drug Development Agreement Based on WEHI's Medicinal Chemistry 2Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products 2Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems 2Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems 3
... Research Park could see some competition soon. A...the Milwaukee area is making plans for an incubato...e County Research Park is straining to fit new co...Biomedical Technology Alliance, so the area needs ... Mascari, director of development at the research ...
...barely receded in Indonesia, Thailand and Sri Lank...ed Nations called the wealthier nations of the wor...icans shrugged off the remark as yet another reaso...t they would have done, anyway: They opened their ... yes, predictable outpouring of private and corpo...
...sity of Wisconsin-Madison received their grades on... grading system was developed and implemented by a...ion of Information Technology and the Office of ...to make available ... in terms of what we would re... for student records in the Office of the Registra...
...ade Computerworld magazines recently released l... , , Christopher A. Graham, vice president and CIO... Church Mutual provides insurance plans to religio...hools, camps and other facilities. It about 90,000...erman Nell, senior vice president and CIO of Fisk...
Other Biology Technology:Milwaukee research alliance sees need for incubator 2Are we stingy on tsunami relief? Not when private giving is counted 2Are we stingy on tsunami relief? Not when private giving is counted 3UW-Madisons move to online grading goes smoothly 2Computerworld: Three Wisconsin CIOs among top 100 IT leaders 2
(Date:7/3/2008)...anal would seem a healthier place for toads than a...rsity of Florida scientists have found the opposit... longstanding debate over whether agricultural che...have found that toads in suburban areas are less l...ties than toads near farms where some had both te...
(Date:7/3/2008)...e the average person can do to stem the rising cos...energy sources. But by improving our energy effici...less energy and save money. , IEEE-USA, in an "E...s that, "Through energy efficiency improvements, t...he depletion of fuel resources; increase energy se...
(Date:7/3/2008)...died the regeneration of the tropical forest in Vi... to tropical forest, but only slowly. Two procedur...ge to free up space for trees and planting the des...el to calculate the appropriate measures. , Peo...and services the forest supplies. However, the nat...
(Date:7/3/2008)...g and live longer? New Saint Louis University rese...promising strategy. , Calorie restriction has l...nd mice. While scientists do not know how calorie ...one popular hypothesis is that it slows aging by d..., which then slows metabolism and tissue aging. ,...
Breaking Biology News(10 mins):New study points to agriculture in frog sexual abnormalities 2New study points to agriculture in frog sexual abnormalities 3IEEE-USA position encourages energy efficiency to save households money, reduce carbon emissions 2Giving nature a helping hand 2Looking for the Founatain of Youth? Cut your calories, research suggests 2New Scrip Report Provides Strategic Insight on the Burgeoning Biosimilars Market 1008 1New Scrip Report Provides Strategic Insight on the Burgeoning Biosimilars Market 1008 2New Scrip Report Provides Strategic Insight on the Burgeoning Biosimilars Market 1008 3Marco Romano MD Joins Chiltern as Medical Director Europe 2706 1Marco Romano MD Joins Chiltern as Medical Director Europe 2706 2Pelosi Statement on National Breast Cancer Awareness Month 2703 1Governor Rendell Calls for Prompt Action on Prescription for Pennsylvania Cover All Pennsylvanians Health Care Reforms 2700 1Governor Rendell Calls for Prompt Action on Prescription for Pennsylvania Cover All Pennsylvanians Health Care Reforms 2700 2
...n tumor cells implanted in mice have shown that th...ead of breast cancer to the lungs. The new studies...veal that the aberrant genes work together to prom...on among the four genes also enables cancerous cel...rough blood vessels into lung tissues. , Although ...
...he first large-scale study to evaluate a candidate...d today by study collaborators in the United State...,000 participants at five sites throughout South A..., The sites are part of the HIV Vaccine Trials Net...nson Cancer Research Center in Seattle and support...
...ueensland University of Technology are one step cl...t women against contracting the most common sexual... vaccine company Sanofi-Pasteur has awarded QUT a ...s research into Chlamydia and work towards develop...men. , Professor Peter Timms, from QUT,s Instit...
...m Université Laval’s Faculty of Medicine have disc...rinkle products causes a pathological reaction in ...nd François Marceau present their conclusions abou...—in the latest edition of the British Journal of D...d in many antiwrinkle products dubbed "instant ant...
Other Biology News:A genetic 'gang of 4' drives spread of breast cancer 2A genetic 'gang of 4' drives spread of breast cancer 3A genetic 'gang of 4' drives spread of breast cancer 4Africa's first large-scale HIV vaccine study launches 2Africa's first large-scale HIV vaccine study launches 3Africa's first large-scale HIV vaccine study launches 4Chlamydia vaccine a step closer to reality 2Anti-wrinkle compound causes pathological reaction in skin cells 2
IMAGEQUANT 300 IQTL, 1 EA. Category: ImageQuant CCD Imagers.
RayBio Human Cytokine Antibody Array 1.1 (4 array membranes) with Accessory, detects 20 cytokines (for lysate) Class: Antibody Array Products Product Group: Antibody Array
Recombinant Feline IL-12/IL-23 p40
Request Info
Biology Products: